Trial intelligence / Profile preview

Panobinostat, Decitabine, and Temozolomide in Metastatic Melanoma

NCT00925132Phase 2Terminated

Sponsor
University of Iowa
Start
Dec 2009
Primary completion
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of panobinostat in melanoma, sponsored by University of Iowa. Started Dec 2009; status: terminated.

02

Drugs

panobinostat
03

Conditions

melanoma

Beyond the preview

Go deeper on NCT00925132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00925132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call